CH589636A5 - - Google Patents

Info

Publication number
CH589636A5
CH589636A5 CH519173A CH519173A CH589636A5 CH 589636 A5 CH589636 A5 CH 589636A5 CH 519173 A CH519173 A CH 519173A CH 519173 A CH519173 A CH 519173A CH 589636 A5 CH589636 A5 CH 589636A5
Authority
CH
Switzerland
Application number
CH519173A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH589636A5 publication Critical patent/CH589636A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH519173A 1972-04-11 1973-04-11 CH589636A5 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00243480A US3816446A (en) 1972-04-11 1972-04-11 (alpha-(3-trifluoromethylphenoxy)-4-chlorobenzyl)heterocycles

Publications (1)

Publication Number Publication Date
CH589636A5 true CH589636A5 (cg-RX-API-DMAC10.html) 1977-07-15

Family

ID=22918919

Family Applications (1)

Application Number Title Priority Date Filing Date
CH519173A CH589636A5 (cg-RX-API-DMAC10.html) 1972-04-11 1973-04-11

Country Status (9)

Country Link
US (1) US3816446A (cg-RX-API-DMAC10.html)
JP (1) JPS5030620B2 (cg-RX-API-DMAC10.html)
CH (1) CH589636A5 (cg-RX-API-DMAC10.html)
DE (1) DE2318002A1 (cg-RX-API-DMAC10.html)
DK (1) DK136976B (cg-RX-API-DMAC10.html)
FR (1) FR2182952B1 (cg-RX-API-DMAC10.html)
GB (1) GB1388790A (cg-RX-API-DMAC10.html)
NL (1) NL7304333A (cg-RX-API-DMAC10.html)
SE (1) SE380524B (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953465A (en) * 1972-04-11 1976-04-27 Merck & Co., Inc. 2-[α-(3-Trifluoromethylphenoxyl)-4-chlorobenzyl]oxazole and methods for preparing the same
US3953490A (en) * 1972-07-13 1976-04-27 Merck & Co., Inc. Preparation of (3-trifluoromethylphenoxy)(4-chlorophenyl)acetonitrile
JPS50116306U (cg-RX-API-DMAC10.html) * 1974-03-05 1975-09-22
JPS50137193U (cg-RX-API-DMAC10.html) * 1974-04-25 1975-11-12
JPS5111502A (en) * 1974-07-19 1976-01-29 Matsushita Electric Industrial Co Ltd Senkyokusochi
JPS544877Y2 (cg-RX-API-DMAC10.html) * 1976-12-03 1979-03-01
ATE5478T1 (de) * 1980-03-05 1983-12-15 Ciba-Geigy Ag Herbizid wirkende 2-nitro-5-phenoxyphenyloxazole, -oxazine, -imidazole, -pyrimidine und - thiazole, ihre herstellung und verwendung.
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
FR2766821A1 (fr) * 1997-07-29 1999-02-05 Sanofi Sa Derives de 1,3-oxazolinyl-biphenyle, leur procede de preparation et leur utilisation comme intermediaires de synthese
EP1366012A4 (en) * 2001-02-09 2005-11-02 Merck & Co Inc 2-ARYLOXY-2-ARYLALKANIC ACIDS AGAINST DIABETES AND FAILURE CHANGES
CA2555814A1 (en) * 2004-02-18 2005-09-01 Metabolex, Inc. Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
WO2005115383A2 (en) 2004-05-25 2005-12-08 Metabolex, Inc. Substituted triazoles as modulators of ppar and methods of their preparation

Also Published As

Publication number Publication date
GB1388790A (en) 1975-03-26
DK136976B (da) 1977-12-27
FR2182952B1 (cg-RX-API-DMAC10.html) 1975-10-31
JPS497275A (cg-RX-API-DMAC10.html) 1974-01-22
SE380524B (sv) 1975-11-10
JPS5030620B2 (cg-RX-API-DMAC10.html) 1975-10-02
DE2318002A1 (de) 1973-10-31
FR2182952A1 (cg-RX-API-DMAC10.html) 1973-12-14
NL7304333A (cg-RX-API-DMAC10.html) 1973-10-15
DK136976C (cg-RX-API-DMAC10.html) 1978-06-05
US3816446A (en) 1974-06-11

Similar Documents

Publication Publication Date Title
CS151852B1 (cg-RX-API-DMAC10.html)
CS155023B1 (cg-RX-API-DMAC10.html)
CS151864B1 (cg-RX-API-DMAC10.html)
CS153434B2 (cg-RX-API-DMAC10.html)
CS153945B1 (cg-RX-API-DMAC10.html)
CS154740B1 (cg-RX-API-DMAC10.html)
CS151860B1 (cg-RX-API-DMAC10.html)
CS159086B1 (cg-RX-API-DMAC10.html)
CS158793B1 (cg-RX-API-DMAC10.html)
CS156937B1 (cg-RX-API-DMAC10.html)
CS155035B1 (cg-RX-API-DMAC10.html)
CS155025B1 (cg-RX-API-DMAC10.html)
CH567112A5 (cg-RX-API-DMAC10.html)
CH578356A5 (cg-RX-API-DMAC10.html)
BG21123A1 (cg-RX-API-DMAC10.html)
CH1065773A4 (cg-RX-API-DMAC10.html)
CH1091873A4 (cg-RX-API-DMAC10.html)
CH1773873A4 (cg-RX-API-DMAC10.html)
NL7304333A (cg-RX-API-DMAC10.html)
CH559071A5 (cg-RX-API-DMAC10.html)
CH559971A5 (cg-RX-API-DMAC10.html)
CH560094A5 (cg-RX-API-DMAC10.html)
CH561039A5 (cg-RX-API-DMAC10.html)
CH565954A5 (cg-RX-API-DMAC10.html)
BG20515A1 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased